Australia markets closed

FibroGen Inc (1FG.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
1.1005-0.0010 (-0.09%)
As of 08:01AM CEST. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-240,460
-284,232
-293,654
-290,023
-189,291
-
Depreciation & amortisation
7,785
9,930
10,604
14,809
22,047
-
Stock-based compensation
43,417
50,767
65,601
71,161
72,720
-
Change in working capital
-107,742
-119,687
70,430
60,083
174,630
-
Accounts receivable
-19,953
3,433
765
25,180
-11,973
-
Inventory
14,031
-1,695
-10,999
-14,158
-9,175
-
Accounts payable
-69,574
-15,514
5,909
805
17,731
-
Other working capital
-274,675
-317,540
-184,674
-112,418
77,608
-
Other non-cash items
-
32,370
1,036
60,000
202
-
Net cash provided by operating activities
-272,718
-315,021
-145,933
-82,232
81,602
-
Cash flows from investing activities
Investments in property, plant and equipment
-1,957
-2,519
-38,741
-30,186
-3,994
-
Acquisitions, net
-
-
0
0
-3,896
0
Purchases of investments
-257,986
-251,830
-164,023
-484,144
-8,192
-
Sales/maturities of investments
360,738
407,350
291,874
87,358
467,506
-
Net cash used for investing activities
101,451
153,657
89,116
-426,972
452,487
-
Cash flows from financing activities
Debt repayment
-324
-484
-538
-5,892
-13,023
-
Common stock issued
17,657
48,407
0
0
37,829
-
Other financing activities
-
-2,983
43,130
-7,372
-11,463
-
Net cash used provided by (used for) financing activities
91,099
122,749
46,776
-563
13,343
-
Net change in cash
-82,816
-42,012
-15,523
-507,170
552,127
-
Cash at beginning of period
188,550
155,700
171,223
678,393
126,266
-
Cash at end of period
108,382
113,688
155,700
171,223
678,393
-
Free cash flow
Operating cash flow
-272,718
-315,021
-145,933
-82,232
81,602
-
Capital expenditure
-1,957
-2,519
-38,741
-30,186
-3,994
-
Free cash flow
-274,675
-317,540
-184,674
-112,418
77,608
-